在帕金森症的药理学模型中,睡眠剥夺诱导晚期有害影响
相关实验视频
Updated: Jun 30, 2025

03:46
Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling
Published on: October 11, 2018
10.1K
L B Lopes-Silva1, D M G Cunha1, A C Lima1
1Behavioral Neuroscience Laboratory, Department of Pharmacology, Universidade Federal de São Paulo (EPM/UNIFESP), Rua Botucatu, 862, Ed. Leal Prado, São Paulo, Brazil.
Experimental brain research
|March 19, 2024
概括
睡眠不足 (SD) 可以使帕金森病的症状恶化. 虽然最初似乎改善了运动功能,但SD最终在小鼠模型中加剧了缺陷和认知障碍,突出了潜在的长期负面影响.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,具有运动和非运动症状.
- 睡眠障碍在PD中很常见,可能会恶化疾病的进展和预后.
- 睡眠不足 (SD) 是影响PD病理的一个潜在因素.
研究的目的:
- 研究睡眠剥夺对小鼠帕金森症进展性药理学模型的影响.
- 评估在储治疗前或期间服用SD对运动和非运动行为的影响.
- 评估与SD和预留药治疗相关的神经化学变化.
主要方法:
- 瑞士雄性小鼠接受了慢性,低剂量reserpine或载体的管理.
- 睡眠剥夺是通过每天6个小时的温和处理来实现的,无论是在储治疗之前还是期间.
- 动物进行了运动评估,物体识别测试和神经化学评估.
主要成果:
- SD增加了运动能力,而储降低了它.
- 治疗前的SD增强了储诱导的触感,表明延迟的有害作用.
- 无论是SD还是reserpine,都会影响认知功能 (对象识别),并诱导类似安赫多尼亚的行为.
- SD增加了海马体的氧化应激;在黑色物质中,reserpine降低了氨酸氧酶.
结论:
- 睡眠不足可能会对帕金森症的进展产生延迟的有害影响.
- SD和reserpine的组合加剧了认知缺陷和无情感.
- 这些发现表明,SD可能会在PD模型中加剧神经退行过程.
相关概念视频
Insufficient Sleep and Sleep Deprivation
143
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
143
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
REM Sleep Behavior Disorder
183
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
183
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244

